Articles -Diabetes & Cardiometabolic Diseases A collection of peer-reviewed articles that provide insights into the latest advancements in diagnosing, treating, and managing diabetes and cardiometabolic diseases, focusing on different types of diabetes and related cardiometabolic conditions. Filter by TopicDiabetesHeart HealthObesityOverviewWeight Management Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial READ MORE Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trial READ MORE Sex differences in cardiometabolic disorders READ MORE Continuous Glucose Monitoring Metrics Predict All-Cause Mortality in Diabetes: A Real-world Long-term Study READ MORE Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic READ MORE Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes READ MORE Ultra processed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomized, crossover trial READ MORE Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023 READ MORE Report on the Joint Symposium of the Korean Society of CardioMetabolic Syndrome (KSCMS) and the Japanese Society of Hypertension (JSH) at the 8th Asia-Pacific CardioMetabolic Syndrome (APCMS) Congress in Seoul READ MORE Association between cardiometabolic index and hypertension among US adults from NHANES 1999–2020 READ MORE Efficacy and safety of combination therapy using SGLT2 and DPP4 inhibitors to treat type 2 diabetes: An updated systematic review and meta-analysis with focus on an Asian subpopulation READ MORE Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial READ MORE Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes READ MORE Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity READ MORE Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes READ MORE 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee READ MORE Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial READ MORE Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches READ MORE Modeling potential cost-effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity READ MORE Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society READ MORE An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists READ MORE Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes READ MORE Tirzepatide as Compared with Semaglutide for the Treatment of Obesity READ MORE Precision nutrition for cardiometabolic diseases READ MORE Patient Adherence for Oral Combination Therapies in Diabetes Management: A Scoping Review READ MORE South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population – An American society for preventive cardiology clinical practice statement READ MORE Metabolic diseases in the East Asian populations READ MORE Effect of once-weekly subcutaneous semaglutide on abdominal visceral fat area in Japanese adults with overweight and obesity: A post hoc analysis of the STEP 6 trial READ MORE Obesity and sexual desire: a systematic review and meta-analysis READ MORE Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes READ MORE Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative Review READ MORE The association between metabolically healthy obesity and risk of depression: a systematic review and meta-analysis READ MORE Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 READ MORE Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial READ MORE Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk READ MORE Definition and diagnostic criteria of clinical obesity READ MORE Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East READ MORE Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning READ MORE The evolving landscape of cardiometabolic diseases READ MORE Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk READ MORE Tackling cardiometabolic disease in southeast Asia: local research to inform local practice READ MORE Tackling cardiometabolic disease in southeast Asia: local research to inform local practice READ MORE Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model READ MORE Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial READ MORE Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 READ MORE The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions READ MORE The metabolic consequences of ‘yo-yo’ dieting are markedly influenced by genetic diversity READ MORE Network modeling approaches for metabolic diseases and diabetes READ MORE Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity READ MORE The association between serum high-density lipoprotein and hemoglobin A1c in T2DM: Evidence from a nationwide cross-sectional study in diabetic patients READ MORE Obesity in the Asia-Pacific Region: Current Perspectives READ MORE Genetics, pharmacotherapy, and dietary interventions in childhood obesity READ MORE Correlation between platelet metrics and cardiovascular risk in prediabetes with coronary artery disease: A two-year cross-sectional study READ MORE Anthropometric measures of obesity as risk indicators for prediabetes. A systematic review and meta-analysis READ MORE Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia–Pacific Region READ MORE The synergistic effect of obesity and dyslipidemia on hypertension: results from the STEPS survey READ MORE Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024 READ MORE Global trends in burden of type 2 diabetes attributable to physical inactivity across 204 countries and territories, 1990-2019 READ MORE Precision Nutrition Unveiled: Gene–Nutrient Interactions, Microbiota Dynamics, and Lifestyle Factors in Obesity Management READ MORE Cardiometabolic Disease Staging and Major Adverse Cardiovascular Event Prediction in 2 Prospective Cohorts READ MORE COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights READ MORE Management of Hypertension in the Asia-Pacific Region: A Structured Review READ MORE ACTION APAC: Understanding perceptions, attitudes and behaviours in obesity and its management across south and Southeast Asia READ MORE What is the pipeline for future medications for obesity? READ MORE Changing landscape of diabetes in Asia – What are the unmet needs? READ MORE A genomics perspective of personalized prevention and management of obesity READ MORE Prevalence of Anemia in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis READ MORE Genetic variant panel allows predicting both obesity risk, and efficacy of procedures and diet in weight loss READ MORE Intensive Lifestyle Intervention for Remission of Early Type 2 Diabetes in Primary Care in Australia: DiRECT-Aus READ MORE The pathophysiology of diabetic foot: a narrative review READ MORE Precision Nutrition to Improve Risk Factors of Obesity and Type 2 Diabetes READ MORE Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime READ MORE Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications READ MORE Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: Insights From Publications Between 2011 and 2020 READ MORE Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity READ MORE Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals READ MORE Motivations for participation in weight loss clinical trials READ MORE Motivations for participation in weight loss clinical trials READ MORE Effect of nature prescriptions on cardiometabolic and mental health, and physical activity: a systematic review READ MORE Clustering of metabolic and behavioural risk factors for cardiovascular diseases among the adult population in South and Southeast Asia: findings from WHO STEPS data READ MORE Current treatment landscape for obesity in Singapore READ MORE Combating obesity: a change in perspectives READ MORE Knowledge, attitude, and practice toward pre-diabetes among the public, patients with pre-diabetes and healthcare professionals: a systematic review READ MORE A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors READ MORE Multi-omics approaches for precision obesity management READ MORE Multi-omics approaches for precision obesity management READ MORE Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program READ MORE Obesity in South and Southeast Asia—A new consensus on care and management READ MORE Lifestyle interventions for cardiometabolic health READ MORE Changes in hyperglycaemia-related testing for prediabetes and type 2 diabetes mellitus management: a prospective, cross-sectional survey of 16 years of general practice data from Australia READ MORE Type 2 diabetes READ MORE Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation READ MORE Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis READ MORE Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations READ MORE Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018 READ MORE Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations READ MORE Why does obesity cause diabetes? READ MORE Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia READ MORE Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices READ MORE Effect of weight loss on erectile function in men with overweight or obesity: A meta-analysis of randomised controlled trials READ MORE The Prevalence and Risk Factors of Hypertension among the Urban Population in Southeast Asian Countries: A Systematic Review and Meta-Analysis READ MORE Dyslipidemia and Cardiometabolic Syndrome READ MORE Tackling cardiometabolic risk in the Asia Pacific region READ MORE COVID-19 and diabetes mellitus: from pathophysiology to clinical management READ MORE Gender differences in central obesity: Implications for cardiometabolic health in South Asians READ MORE The 2017 Focused Update of the Guidelines of theTaiwan Society of Cardiology (TSOC) and theTaiwan Hypertension Society (THS) for theManagement of Hypertension READ MORE A Consensus of Key Opinion Leaders on the Management of Pre-diabetes in the Asia-Pacific Region READ MORE β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians READ MORE Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States READ MORE Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome READ MORE How would you rate this content? Submit Rating
